bioRxiv / medRxiv
open access
CC0 1.0
Oncogene Driver Status Modulates TP53 Prognostic Impact in Advanced NSCLC
PurposeWe compared the association of concurrent TP53 pathogenic variants (PV) with overall survival (OS) by driver status in non-small cell lung cancer (NSCLC). Patients and MethodsThe discovery cohort included 3,295 patients with stage IV NSCLC treated at Kaiser Permanent Northern California. The
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer#1351152
- Prognostic usefulness of advanced lung cancer inflammation index in locally-advanced pancreatic carcinoma patients treated with radical chemoradiotherapy#955712
- EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients#890026
- Dasatinib in Advanced Squamous Cell Lung Cancer#995243
- Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer#834044
Record · ID 1227705
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive